EarlyTox Caspase-3/7 R110 Assay Kit

EarlyTox Caspase-3/7 R110 Assay Kit

  • $362.00

For more information on assay kit and instrument compatibility, please click here.

Please note: Online purchases of assay kits are currently limited to shipping addresses within the United States. Please click here for more information on purchasing assay kits outside of the United States.

For complete Terms and Conditions, please click here.

This kit enables analysis of apoptosis based on caspase-3/7 activity and its consensus target sequence, Asp-Glu-Val-Asp (DEVD). Caspase-3 and caspase-7 are proteases that are activated during the execution phase of apoptosis. This kit provides a single-step, homogenous assay that is specifically designed for microplate readers. The fluorogenic substrate (Ac-DEVD)2-R110 contains two DEVD consensus target sequence and is completely hydrolyzed in cell lysate by the enzymes. Hydrolysis of both DEVD peptides releases the green fluorescent dye R110, resulting in a substantial fluorescence increase, with excitation at 490 nm and emission at 520 nm. The assay kit includes the competitive caspase-3/7 inhibitor Ac-DEVD-CHO for use as a negative control. R110 is also provided in the kit for generating a standard curve, which can be used for quantifying caspase-3 activity.  



    Available Configurations:

     Configuration Description Part Number

    Explorer Kit

    • (1) vial of Rhodamine 110 (80 µM, 1 mL)
    • (2) vials of caspase-3 inhibitor (5 mM, 20 µL)
    • (2) vials of DEVD-R110 (2 mM, 500 µL)
    • (2) vials of lysis buffer (10 mL)

      Each kit contains enough material for two (2) 96-well or 384-well microplates.



    We Also Recommend